Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.

156 total trials for this combination

Showing top 10 of 156 trials

Trials

NCT ID	Title	Status	Phase
NCT01991795	A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT06066528	A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight	COMPLETED	—
NCT07215559	A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	RECRUITING	PHASE2
NCT01336023	Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT01042769	A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT01959529	A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events	COMPLETED	PHASE3
NCT02065791	Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy	COMPLETED	PHASE3
NCT01032629	CANVAS - CANagliflozin cardioVascular Assessment Study	COMPLETED	PHASE3
NCT00968708	Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome	COMPLETED	PHASE3
NCT05514535	A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)	COMPLETED	PHASE3

Related Pages

All Diabetes mellitus, type 2 trials All trials in Atlanta, United States